NEW YORK, May 23 (GenomeWeb News) - Ortho-McNeil Pharmaceutical has licensed another part of Cellzome's proteomics-based Alzheimer's disease program, exercising an option under the terms of a collaboration signed between the two companies in March, Cellzome said today.

 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.